Barings LLC Abbott Laboratories Transaction History

Barings LLC

$4.06 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $55,016 - $64,757	-568 Reduced 18.54%	2,495 $252,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $4,182 - $4,906	-44 Reduced 1.42%	3,063 $336,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $482,542 - $558,693	-4,987 Reduced 61.61%	3,107 $301,000
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $278,344 - $336,429	2,727 Added 50.81%	8,094 $880,000
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $553,111 - $674,483	-4,851 Reduced 47.48%	5,367 $636,000
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $52,335 - $64,081	-453 Reduced 4.25%	10,218 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $456,723 - $505,269	-3,915 Reduced 26.84%	10,671 $1.26 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $117,215 - $137,979	-1,108 Reduced 7.06%	14,586 $1.69 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $407,605 - $480,221	3,745 Added 31.34%	15,694 $1.88 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $1.98 Million - $2.16 Million	-18,886 Reduced 61.25%	11,949 $1.31 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $834,748 - $1.01 Million	9,109 Added 41.93%	30,835 $3.36 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $440,242 - $643,754	7,008 Added 47.62%	21,726 $1.72 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $2.25 Million - $2.5 Million	-28,637 Reduced 66.05%	14,718 $1.28 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $1,554 - $1,686	19 Added 0.04%	43,355 $3.63 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $2.73 Million - $3.18 Million	37,423 Added 632.89%	43,336 $3.65 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $1.68 Million - $2.03 Million	-25,300 Reduced 81.06%	5,913 $473,000
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $2.23 Million - $2.68 Million	-36,600 Reduced 53.97%	31,213 $2.29 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $234,712 - $259,052	-4,077 Reduced 5.67%	67,813 $4.14 Million
Q4 2017 Feb 08, 2018	SELL	$53.68 - $57.47 $2.37 Million - $2.53 Million	-44,100 Reduced 38.02%	71,890 $4.1 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $3.14 Million - $3.5 Million	65,300 Added 128.82%	115,990 $6.19 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-13,253 Reduced 20.73%	50,690 $2.46 Million
Q2 2017 Aug 14, 2017	BUY	N/A	63,943	63,943 $0

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account